Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here to find out why VRTX is a Buy.

I play a lot of competitive shooters – and I mean a lot of competitive shooters. Whether it’s being an unfortunate son in Grey Zone Warfare, flipping cards in FragPunk, or smashing and grabbing in The ...

Vertex has begun a full-court press for Journavx, enlisting NBA All-Star Jayson Tatum to discuss his use of the new ...

Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Vertex also announced enrollment completion of the IA cohort of AMPLITUDE, a global Phase 2/3 clinical trial designed to assess the impact of ...

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.

As previously reported, Leerink upgraded Vertex Pharmaceuticals (VRTX) to Outperform from Market Perform with a price target of $456, down from ...

It is officially the most wonderful time of the year at Hallmark, with dozens of original films set to hit the 2025 Christmas movie calendar between now and December 25. The network known for the ...